Concepedia

Zvezdana Hlebanja

ZH

4

Publications

168

Citations

4

H-Index

1996

Active since

Affiliations

Institute of Oncology Ljubljana(Current)

Zvezdana Hlebanja is an author at Institute of Oncology Ljubljana specializing in liver, liver physiology, and oncology.

Top concepts

Publications per year

1996–2011

4

Publications

4

Capecitabine plus Irinotecan (XELIRI regimen) compared to 5-FU/LV plus Irinotecan (FOLFIRI regimen) as neoadjuvant treatment for patients with unresectable liver-only metastases of metastatic colorectal cancer: a randomised prospective phase II trial

Erik Škof, Martina Reberšek, Zvezdana Hlebanja et al. · BMC Cancer · 2009 · 69 citations · Full text

Spontaneous regression of hepatocellular carcinoma.

Slobodan Marković, Ferlan‐Marolt, Zvezdana Hlebanja · PubMed · 1996 · 57 citations

, , +15

Randomized Prospective Phase II Study to Compare the Combination Chemotherapy Regimen Epirubicin, Cisplatin, and 5-Fluorouracil With Epirubicin, Cisplatin, and Capecitabine in Patients With Advanced or Metastatic Gastric Cancer

Janja Ocvirk, Martina Reberšek, Erik Škof et al. · American Journal of Clinical Oncology · 2011 · 24 citations

Efficacy of first-line systemic treatment in correlation with BRAF V600E and different KRAS mutations in metastatic colorectal cancer - a single institution retrospective analysis

Martina Reberšek, Marko Boc, Petra Cerkovnik et al. · Radiology and Oncology · 2011 · 18 citations · Full text

Rows per page

1–4 of 4